» Authors » Kent E Hutchison

Kent E Hutchison

Explore the profile of Kent E Hutchison including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 163
Citations 4180
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Melendez S, Ortiz Torres M, Lisano J, Giordano G, Skrzynski C, Hutchison K, et al.
Front Pharmacol . 2024 Oct; 15:1464005. PMID: 39380911
Introduction: Cannabis, commonly known for both therapeutic and intoxicating effects, is gaining accessibility on legal markets and traction as a potential alternative therapy for pain mediation, particularly in those suffering...
2.
Bidwell L, Martin-Willett R, Melendez S, Rosa L, Giordano G, Hutchison K, et al.
PLoS One . 2024 Sep; 19(9):e0308262. PMID: 39348366
Background: As cannabis legalization continues to spread across the United States, average Δ9-tetrahydrocannabinol concentrations in recreational products have significantly increased, and no prior study has evaluated effective treatments to reduce...
3.
Qiu L, Liang C, Kochunov P, Hutchison K, Sui J, Jiang R, et al.
Transl Psychiatry . 2024 Aug; 14(1):326. PMID: 39112461
People affected by psychotic, depressive and developmental disorders are at a higher risk for alcohol and tobacco use. However, the further associations between alcohol/tobacco use and symptoms/cognition in these disorders...
4.
Lin D, Fu Z, Liu J, Perrone-Bizzozero N, Hutchison K, Bustillo J, et al.
Schizophr Res . 2024 Jul; 270:392-402. PMID: 38986386
Recent microbiome-brain axis findings have shown evidence of the modulation of microbiome community as an environmental mediator in brain function and psychiatric illness. This work is focused on the role...
5.
Chen M, Kramer E, Gibson L, Bidwell L, Hutchison K, Bryan A
Cannabis Cannabinoid Res . 2024 Apr; 10(1):71-80. PMID: 38608236
Cannabis has been touted for a host of pharmacological and therapeutic effects and users commonly report reduced symptoms of physical and mental health conditions, including anxiety, depression, and chronic pain....
6.
Bidwell L, Martin-Willett R, Skrzynski C, Lisano J, Ortiz Torres M, Giordano G, et al.
Cannabis Cannabinoid Res . 2024 Jan; 9(4):1015-1027. PMID: 38252547
Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have varying pharmacological actions with differential effects on acute and extended affective states, incuding anxiety. We aimed to study these effects on anxiety in legal...
7.
Lin D, Fu Z, Liu J, Perrone-Bizzozero N, Hutchison K, Bustillo J, et al.
bioRxiv . 2024 Jan; PMID: 38234846
Recent microbiome-brain axis findings have shown evidence of the modulation of microbiome community as an environmental mediator in brain function and psychiatric illness. This work is focused on the role...
8.
Gibson L, Giordano G, Bidwell L, Hutchison K, Bryan A
Sports Med . 2023 Dec; 54(4):1051-1066. PMID: 38147185
Objective: The present study aimed to examine the acute effects of legal-market cannabis on regular cannabis users' subjective responses to exercise in a controlled laboratory environment. Background: Given the stereotype...
9.
Skrzynski C, Bryan A, Hutchison K
Psychol Addict Behav . 2023 May; 38(1):92-100. PMID: 37199963
Objective: This study compared two mechanisms by which mindfulness may reduce hazardous drinking: effortful control and craving, "top-down" and "bottom-up" processes, respectively. These relationships were compared in a secondary analysis...
10.
Skrzynski C, Karoly H, Ellingson J, Hagerty S, Bryan A, Hutchison K
J Stud Alcohol Drugs . 2023 Mar; 84(4):560-569. PMID: 36971735
Objective: This study compared the efficacy of mindfulness-based relapse prevention (MBRP) with relapse prevention (RP) on reducing alcohol consumption. Secondary, exploratory aims assessed moderation of treatment effects by sex and...